Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon.

Jason G Powell Christopher R Piszczatoski

Published in: The Annals of pharmacotherapy (2022)

Data available show a high efficacy rate of preventing SARS -CoV-2 with relatively low rates of ADE after full vaccination with Pfizer-BioNTech COVID-19 vaccine.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
electronic health record
big data
deep learning
drug administration